Literature DB >> 23319220

Cerebral vasoreactivity in hypocapnia and hypercapnia in patients with diabetes mellitus type 2 with or without arterial hypertension.

Anetta Lasek-Bal1, Zofia Kazibutowska, Anna Gołba, Ewa Motta.   

Abstract

BACKGROUND AND
PURPOSE: Diabetes mellitus (DM) is an in-dependent risk factor for cardiovascular diseases. The origin of diabetic microangiopathy is multifactorial; it affects all layers of the artery wall, causing endothelial and vasoreactivity impairment. The incidence of cerebral vasoreactivity failure in diabetic patients without stroke history is not precisely determined yet. The aim of the study was to assess the cerebrovascular reactivity in hypocapnia and hypercapnia in patients with type 2 DM with or without arterial hypertension without artery stenosis and stroke history, with the use of transcranial Doppler examination.
MATERIAL AND METHODS: The mean blood flow velocity, pulsatility index and parameters of cerebrovascular reactivity were measured in 53 patients with type 2 DM (aged 42-72 years, mean 59.5 ± 7.9) and in 27 healthy volunteers (aged 36- 74 years, mean 57.0 ± 10.4). Diabetics were further divided into two subgroups according to the presence or absence of arterial hypertension.
RESULTS: The index of cerebrovascular reactivity in hypocapnia and hypercapnia was significantly worse and time needed to normalization of blood flow velocity was significantly longer in patients with DM in comparison with healthy volunteers.
CONCLUSIONS: Most DM type 2 patients without stroke history had decreased values of cerebral vasoreactivity parameters, which suggests the presence of microangiopathy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23319220     DOI: 10.5114/ninp.2012.32175

Source DB:  PubMed          Journal:  Neurol Neurochir Pol        ISSN: 0028-3843            Impact factor:   1.621


  2 in total

1.  Cerebrovascular CO2 reactivity during isoflurane-nitrous oxide anesthesia in patients with chronic renal failure.

Authors:  Kazuyoshi Ishida; Masato Uchida; Kohji Utada; Atsuo Yamashita; Satoshi Yamashita; Shiro Fukuda; Mishiya Matsumoto; Takefumi Sakabe
Journal:  J Anesth       Date:  2017-11-04       Impact factor: 2.078

2.  Inflammation-associated declines in cerebral vasoreactivity and cognition in type 2 diabetes.

Authors:  Chen-Chih Chung; Daniela Pimentel; Azizah J Jor'dan; Ying Hao; William Milberg; Vera Novak
Journal:  Neurology       Date:  2015-07-08       Impact factor: 9.910

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.